Bel Air Pharmaceuticals
Focus: Bel Air Pharmaceuticals is a newly founded (2024) specialty pharmaceutical company headquartered in Beverly Hills focused on diagnostics, wound care, pain management, and neurology. The company operates a portfolio of established branded and generic products with heavy revenue concentration in a single asset.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Bel Air Pharmaceuticals
AI assessmentNot HiringNo open roles listed right now. Follow Bel Air Pharmaceuticals to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
1 in 5yr
ONMEL
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$769K Part DStable
Peak6.9yr
Flagship revenue driver representing 60% of company revenue; patent protection extends to 2033.
Help build intelligence for Bel Air Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.